- Tytuł:
- Mericitabine and Either Boceprevir or Telaprevir in Combination with Peginterferon Alfa-2a plus Ribavirin for Patients with Chronic Hepatitis C Genotype 1 Infection and Prior Null Response: The Randomized DYNAMO 1 and DYNAMO 2 Studies.
- Autorzy:
- Źródło:
- PloS one [PLoS One] 2016 Jan 11; Vol. 11 (1), pp. e0145409. Date of Electronic Publication: 2016 Jan 11 (Print Publication: 2016).
- Typ publikacji:
- Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Antiviral Agents/*therapeutic use
Deoxycytidine/*analogs & derivatives
Hepatitis C, Chronic/*drug therapyInterferon-alpha /*therapeutic use
Oligopeptides/*therapeutic use
Polyethylene Glycols/*therapeutic use
Proline/*analogs & derivatives
Ribavirin/*therapeutic use
Adult ; Antibodies, Viral/biosynthesis ; Antibodies, Viral/blood ; Antimetabolites/therapeutic use ; Deoxycytidine/therapeutic use ; Double-Blind Method ; Drug Administration Schedule ; Drug Therapy, Combination/methods ; Female ; Genotype ; Hepacivirus/drug effects ; Hepacivirus/enzymology ; Hepacivirus/growth & development ; Hepatitis C, Chronic/immunology ; Hepatitis C, Chronic/pathology ; Hepatitis C, Chronic/virology ; Humans ; Male ; Middle Aged ; Proline/therapeutic use ; Protease Inhibitors/therapeutic use ; RNA, Viral/antagonists & inhibitors ; RNA, Viral/genetics ; Recombinant Proteins/therapeutic use ; Treatment Outcome
Czasopismo naukowe